This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
Bibliography
Group HomeGroup HomeGroup PagesDirectory & Features Join Group
Share |

The following is a bibliography of official communications and guidance from the SSC Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. They are organized by year and volume.

 

Journal of Thrombosis and Haemostasis

Volume 17 (2019)

Hubbard, ARThelwell, CRigsby, Pfor the Subcommittee on Factor VIII, Factor IX and Rare Coagulation DisordersEstablishment of the WHO 2nd International Standard Factor V, plasma (16/374): communication from the SSC of the ISTHJ Thromb Haemost 201917695– 7.

Volume 16 (2018)

Makris M, Oldenburg J, Mauser‐Bunschoten EP, Peerlinck K, Castaman G, Fijnvandraat K, for the Subcommittee on Factor VIII, Factor IX and Rare Bleeding Disorders. The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTHJ Thromb Haemost 201816: 2530–3.

Mancuso ME, Bidlingmaier C, Mahlangu JN, Carcao M, Tosetto A, for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTHJ Thromb Haemost 201816: 2106–10.

Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A, for the Subcommittee on Factor VIII, Factor IX, and Rare Bleeding Disorders. Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTHJ Thromb Haemost 201816: 1437–41.

 

Volume 15 (2017)

Iorio ABlanchette VBlatny JCollins PFischer KNeufeld E, for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTHJ Thromb Haemost 201715246165.

Peyvandi, F, Makris, M, Collins, P, Lillicrap, D, Pipe S. W, Iorio, A, Rosendaal, F. R, and for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. Minimal dataset for post-registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 2017; 15: 1878-1881.

Dargaud, Y, Wolberg, A. S, Gray, E, Negrier, C, Hemker, H. C. and for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 2017; 15: 1704-1707.

 

Volume 14 (2016)

Iorio, A,  Barbara, A.M, Bernardi, F, Lillicrap, D, Makris, M, Peyvandi, F, Rosendaal, F and for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 2016; 14: 1668-1672.

 

Volume 13 (2015)

Dimichele D. M, Lacroix-Desmazes S, Peyvandi F, Srivastava A,  Rosendaal F.R. and for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTH. J. Thromb Haemost 2015; 13: 876-879.

 

Volume 12 (2014)

Blanchette, V. S, N. S. Key, L. R. Ljung, M. J. Manco-Johnson, H. M. van den Berg, A. Srivastava and for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. Definitions in hemophilia: communication from the SSC of the ISTH. J Throm Haemost 2014; 12:1935-1939.  

Thelwell, C, P. Rigsby, S. Bevan, M. Beeharry and for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. An international collaborative study to establish the World Health Organization 2nd International Standard for Factor VII Concentrate: communication from the SSC of the ISTH. J Throm Haemost 2014; 12 1750-1753.

Chiltur M, Rivard E, Lillicrap D, Mann K, Shima M, Young G. On behalf of the Factor VIII, Factor IX, and Rare Coagulation Disorders Subcommittee of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.  Recommendations for performing thromboelastography/thromboelastrometry in hemophilia: communication from the SSC of the ISTH. J Throm Haemost 2014; 12: 103-6.

 

Volume 11 (2013)

Hubbard AR, Dodt J, Lee T, Mertens K, Seitz R, Srivastava A, Weinstein M. On Behalf of the Factor VIII and Factor IX Subcommittee of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Recommendations on the potency labelling of factor VIII and factor IX concentrates. J Thromb Haemost 2013; 11: 988–9.

Björkman, S., Collins, P. and for the Project on Factor VIII/Factor IX Pharmacokinetics of the Factor VIII/Factor IX Scientific and Standardization Committee of the ISTH (2013), Measurement of factor VIII pharmacokinetics in routine clinical practice. Journal of Thrombosis and Haemostasis, 11: 180–182.

 

Volume 10 (2012)

Peyvandi, F., Di Michele, D., Bolton-Maggs, P. H. B., Lee, C. A., Tripodi, A., Srivastava, A. and for the Project on Consensus Definitions in Rare Bleeeding Disorders of the Factor VIII/Factor IX Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis (2012), Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. Journal of Thrombosis and Haemostasis, 10: 1938–1943.

Raut, S., Daniels, S., Heath, A. B. and on behalf of the SSC Sub-Committee on factor VIII/IX of ISTH (2012), Value assignment of the WHO 8th International Standard for factor VIII, concentrate (07/350). Journal of Thrombosis and Haemostasis, 10: 1175–1176.

 

Volume 9 (2011)

Hubbard, A. R., Hamill, M., Beeharry, M., Bevan, S. A., Heath, A. B. and on behalf of the SSC Sub-Committees on Factor VIII/Factor IX and von Willebrand factor of ISTH (2011), Value assignment of the WHO 6th International Standard for blood coagulation factor VIII and von Willebrand factor in plasma (07/316). Journal of Thrombosis and Haemostasis, 9(10): 2100–2102.

 

Volume 5 (2007)

Hubbard A R., Weller L J , Johnes S, on behalf of the SSC Subcommittee on Factor VIII and Factor IX. Calibration of the WHO 1st International Standard for blood coagulation factor V in plasma, human (03/116). J Thromb Haemost 2007; 5 (6), 1318-1319

 

Additional Past Communications


 

 

 

 

Membership Management Software Powered by YourMembership  ::  Legal